Tuberculosis AB
Tuberculosis AB
Tuberculosis: Texts
Text A
Tuberculosis
Tuberculosis is an infectious disease caused in most cases by a micro-organism called Mycobacterium tuberculosis.
The micro-organisms usually enter the body by inhalation through the lungs. They spread from the initial location in the
lungs to other parts of the body via the blood stream, the lymphatic system, the airways or by direct extension to other
organs.
• Pulmonary tuberculosis is the most frequent form of the disease, usually comprising over 80% of cases. It is the
form of tuberculosis that can be contagious.
• Extra-pulmonary tuberculosis is tuberculosis affecting organs other than the lungs, most frequently pleura, lymph
nodes, spine and other bones and joints, genitourinary tract, nervous system, abdomen or virtually any organ.
Tuberculosis may affect any part of the body, and may even become widely disseminated throughout the whole
body.
Tuberculosis develops in the human body in two stages. The first stage occurs when an individual who is exposed
to micro-organisms from an infectious case of tuberculosis becomes infected and the second is when the in-
fected individual develops the disease.
Diagnosis of tuberculosis
For drug-resistant TB, a combination of antibiotics called fluoroquinolones and injectable medications such as amikacin,
kanamycin or capreomycin are generally used for 20-30 months.
• People with active TB disease should stay away from work and school until the doctor says it’s safe to return, in
order to avoid infecting others.
• Cover the mouth with a tissue when coughing and sneezing, then seal the tissue in a bag to throw it away.
• Make sure the patient’s room has adequate ventilation, so that the exhaled bacteria are carried away.
• People with active disease need to tell their doctor or health professionals about anyone they have had close
contact with, such as family, friends.
• Take all the medications on right time. If patient stop taking medications or skip some doses, the risk of developing
drug resistant TB is high.
Tuberculosis: Questions
Questions 1-6
For each of the questions 1-7, decide which text (A,B, C or D) the information comes from. You may use any
letter more than once.
in household setting
2. Indicators of the disease ____________________ __________
Questions 7-14
Answer each of the questions, 8-14, with a word or short phrase from one of the texts. Each answer may
include words, numbers or both.
8. Which is the drug used for TB skin test?
_______ ______________________________________________ _______
11. How long does a patient have to take medication for drug-resistant TB?
_______ ______________________________________________ _______
Questions 15-20
Complete each of the sentences, 15-20, with a word or a short phrase from one of the texts. Each answer
may include words, numbers or both.
19. is suspected on patients who visit the health sector on their own interest.
END OF PART A
Mandatory requirements
• All adult patients admitted to NSW public hospitals must be assessed for the risk of VTE within 24 hours
and regularly as indicated / appropriate.
• All adult patients discharged home from the Emergency Department who as a result of acute illness or
injury, have significantly reduced mobility relative to normal state, must be assessed for risk of VTE.
• Patients identified at risk of VTE are to receive the pharmacological and / or mechanical prophylaxis
most appropriate to that risk and their clinical condition.
• All health services must comply with the Prevention of VTE Policy.
• All Public Health Organisations must have processes in place in compliance with the actions summarised
in the VTE Prevention Framework (Appendix 4.1 of the attachment). A VTE risk assessment must be
completed for all admitted adult patients and other patients identified at risk, and decision support tools
made available to guide prescription of prophylaxis appropriate for the patients risk level.
Medical monitoring guidelines for high risk patients on very low energy diets
Each EHC follows a standard outline or format, and you can expect to find a summary of the whole
document followed by information on identity, sources of exposure, environmental transport, distribution
and transformation, environmental levels and human exposure, kinetics and metabolism in laboratory
animals and humans, effects on laboratory animals and in vitro test systems.An overall evaluation and
conclusions for the protection of human health and the environment is found at the end of each document
together with needs for further research and details of previous evaluations by international bodies e.g.
IARC, JEFCA.
Two different series of Environmental Health Criteria (EHC) documents are available: (1) on specific
chemicals or groups of related chemicals; and (2) on risk assessment methodologies. Both are acces-
sible from the numerical listing below. In addition the EHCs on risk assessment methodologies are acces-
sible from the listing of all IPCS methodology publications and projects.
Key reasons for deciding to refer either an emergency or a routine case include seeking: